125 related articles for article (PubMed ID: 2927284)
21. Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex.
Md Anisuzzaman AS; Nishimune A; Yoshiki H; Uwada J; Muramatsu I
J Pharmacol Exp Ther; 2011 Oct; 339(1):186-93. PubMed ID: 21719469
[TBL] [Abstract][Full Text] [Related]
22. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
23. An approach to analysis of radiolabeled ligand interactions with specific receptors.
Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
[TBL] [Abstract][Full Text] [Related]
24. Muscarinic cholinergic receptor binding in rat brain at 15 days following traumatic brain injury.
Jiang JY; Lyeth BG; Delahunty TM; Phillips LL; Hamm RJ
Brain Res; 1994 Jul; 651(1-2):123-8. PubMed ID: 7922558
[TBL] [Abstract][Full Text] [Related]
25. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
Alonso R; Didier M; Soubrie P
J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
[TBL] [Abstract][Full Text] [Related]
26. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
27. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites.
Araujo DM; Lapchak PA; Regenold W; Quirion R
Synapse; 1989; 4(2):106-14. PubMed ID: 2781463
[TBL] [Abstract][Full Text] [Related]
28. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain.
Katayama S; Kito S; Miyoshi R; Matsubayashi H
Brain Res; 1987 Sep; 422(1):168-71. PubMed ID: 3676778
[TBL] [Abstract][Full Text] [Related]
29. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
[TBL] [Abstract][Full Text] [Related]
30. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
31. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
Brown JH; Goldstein D
J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
[TBL] [Abstract][Full Text] [Related]
32. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
33. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line.
Ray P; Middleton W; Berman JD
J Neurochem; 1989 Feb; 52(2):402-9. PubMed ID: 2562988
[TBL] [Abstract][Full Text] [Related]
35. Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate.
Cioffi CL; el-Fakahany EE
Eur J Pharmacol; 1986 Dec; 132(2-3):147-54. PubMed ID: 3816972
[TBL] [Abstract][Full Text] [Related]
36. An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptor.
Ehlert FJ; Jenden DJ; Ringdahl B
Life Sci; 1984 Mar; 34(10):985-91. PubMed ID: 6700365
[TBL] [Abstract][Full Text] [Related]
37. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
Das S; Matwyshyn GA; Bhargava HN
Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
[TBL] [Abstract][Full Text] [Related]
38. Presynaptic cholinergic mechanisms in the rat cerebellum: evidence for nicotinic, but not muscarinic autoreceptors.
Lapchak PA; Araujo DM; Quirion R; Collier B
J Neurochem; 1989 Dec; 53(6):1843-51. PubMed ID: 2809595
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
40. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
